Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine
2023 · Nature Medicine · 187 citations
https://doi.org/10.1038/s41591-023-02502-5
I
Ingrid Libman
Broad Institute(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
253
Papers
8.1K
Citations
45
h-index
110
i10-index
Ingrid Libman is an academic researcher from Broad Institute. The author has contributed to research in topics: Diabetes Management and Research & Diabetes and associated disorders & Pancreatic function and diabetes. The author has an h-index of 45, co-authored 216 publications.
ORCID: 0000-0002-0255-4555Papers by this author
worksA Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk
2018 · Diabetes Care · 165 citations
https://doi.org/10.2337/dc18-0087
Effective interventions in preventing gestational diabetes mellitus: A systematic review and meta-analysis
2024 · Communications Medicine · 42 citations
https://doi.org/10.1038/s43856-024-00491-1
Precision prognostics for cardiovascular disease in Type 2 diabetes: a systematic review and meta-analysis
2024 · Communications Medicine · 39 citations
https://doi.org/10.1038/s43856-023-00429-z
Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review
2024 · Communications Medicine · 38 citations
https://doi.org/10.1038/s43856-024-00478-y
Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review
2023 · Communications Medicine · 33 citations
https://doi.org/10.1038/s43856-023-00359-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat